HUMANIN 10 MG

Dragon Pharma Humanin 10 mg – Mitochondrial-Derived Peptide for Cytoprotection Research

Dragon Pharma Humanin 10 mg is a 24-amino-acid peptide encoded within the mitochondrial genome that functions as a cytoprotective, anti-apoptotic, and anti-inflammatory signaling molecule. This naturally occurring peptide has been extensively studied for its ability to preserve cell viability, regulate metabolic homeostasis, and protect tissues against oxidative stress and neurodegenerative conditions.

Each vial contains 10 mg of lyophilized Humanin in a 2 mL format, requiring reconstitution with bacteriostatic water before use. Humanin represents a unique class of mitochondrial-derived peptides that provide insights into mitochondrial signaling, cellular survival pathways, and age-related disease mechanisms. For related research compounds, explore our peptides category and specifically SS-31 50 mg for complementary mitochondrial function research applications.

What Makes Humanin Valuable in Research?

Humanin is a pioneering member of the mitochondrial-derived peptide family, encoded within the mitochondrial genome and distinct from nuclear-encoded peptides. Its discovery has opened new avenues for understanding mitochondrial signaling and its role in cellular survival, metabolism, and aging. Humanin has demonstrated cytoprotective effects against a variety of cellular stressors, including amyloid-beta toxicity, oxidative stress, and apoptotic stimuli.

Researchers value Humanin for its unique origin and pleiotropic biological activities. Its ability to modulate insulin signaling, protect against neurodegenerative conditions, and regulate inflammatory responses makes it relevant to research areas including neurobiology, metabolism, and aging. For investigators exploring other mitochondrial-targeted compounds, MOTS-C offers complementary research avenues in metabolic regulation and mitochondrial function.

Current scientific literature on Humanin can be accessed through the PubMed database, where researchers can review peer-reviewed studies on its biological activity and experimental applications.

Key Research Applications for Dragon Pharma Humanin

• ✔ Investigation of mitochondrial-derived peptide signaling pathways
• ✔ Evaluation of cytoprotective and anti-apoptotic mechanisms
• ✔ Research on neuroprotection and neurodegenerative disease models
• ✔ Studies of metabolic regulation and insulin sensitivity
• ✔ Preclinical models of oxidative stress and cellular aging

Product Details

Dosage & Usage Guidelines

Reconstitution Protocol

• ✔ Use sterile bacteriostatic water for injection
• ✔ Add appropriate volume to achieve desired concentration
• ✔ Swirl gently to dissolve – do not shake vigorously
• ✔ Store reconstituted solution at 2–8°C

Reconstitute the lyophilized powder using bacteriostatic water to a concentration suitable for your research protocol. The 10 mg format allows for flexible dosing across a range of experimental models. Always use aseptic technique during preparation to maintain peptide integrity.

Typical Research Parameters

In research settings, Humanin is typically administered via subcutaneous or intraperitoneal injection. Dosing schedules and concentrations vary widely depending on the experimental design, animal model, and specific research objectives.

• ✔ Commonly used in neuroprotection and cell survival studies
• ✔ Often combined with histological and molecular analysis
• ✔ Used to investigate mitochondrial signaling pathways
• ✔ Research models include neurodegeneration, metabolic disorders, and aging paradigms

Factors to Consider in Research Protocols

• Mitochondrial-derived peptide with specific signaling mechanisms
• Reconstitution stability is limited; prepare fresh solutions for each use
• Individual variation in response may be observed across subjects
• Storage conditions significantly impact peptide stability

Lab Testing & Batch Transparency

Lab status

COA pending release

Third-party analytical testing (COA) for Dragon Pharma Humanin 10 mg is currently not yet available. Batch-specific assay data, purity analysis, and verification documentation will be published once released.

Testing Status

Pending

COA Availability

Not yet published

Batch Verification

In progress

Update

Coming soon

Transparency note: Dragon Pharma publishes batch-specific lab reports once analytical testing is completed and verified.

Awaiting COA

Shipping & Product Authenticity

What to Expect

• ✔ Orders are processed after payment confirmation
• ✔ USA Domestic shipping is typically faster when local stock is selected
• ✔ International orders include tracking, though update frequency may vary by destination
• ✔ Multiple warehouses may result in separate shipments when applicable

For complete delivery details, tracking policy, and reshipment terms, please see our Shipping Info page.

Storage

Store the lyophilized powder at controlled room temperature (15–25°C) in a dry, dark place, away from direct light and moisture. The unopened vial should be kept in its original packaging to maintain stability.

After reconstitution, store the solution at 2–8°C and use within 14 days. Do not freeze. Discard any unused portion after the recommended storage period. Before use, inspect the solution and avoid use if it appears cloudy, discolored, or contains particulate matter, or if the vial or seal is compromised.

Keep out of reach of children. Follow proper handling and sterile injection practices during research use.

Proper storage conditions help maintain product stability and consistent performance across the product's shelf life.

Frequently Asked Questions